Apoptin is a small molecular weight protein encoded by the VP3 gene of chicken anemia virus (CAV). It can induce apoptosis of tumor cells and play anti-tumorigenic functions. In this study, we identified a time-dependent inhibitory role of apoptin on the viability of HCT116 cells. We also demonstrated that apoptin induces pyroptosis through cleaved caspase 3, and with a concomitant cleavage of gasdermin E (GSDME) rather than GSDMD. GSDME knockdown switched the apoptin-induced cell death from pyroptosis to apoptosis . Furthermore, we demonstrated that the effect of apoptin on GSDME-dependent pyroptosis could be mitigated by caspase-3 and caspase-9 siRNA knockdown. Additionally, apoptin enhanced the intracellular reactive oxygen species (ROS), causing aggregation of the mitochondrial membrane protein Tom20. Moreover, bax and cytochrome c were released to the activating caspase-9, eventually triggering pyroptosis. Therefore, GSDME mediates the apoptin-induced pyroptosis through the mitochondrial apoptotic pathway. Finally, using nude mice xenografted with HCT116 cells, we found that apoptin induces pyroptosis and significantly inhibits tumor growth. Based on this mechanism, apoptin may provide a new strategy for colorectal cancer therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741846 | PMC |
| http://dx.doi.org/10.7150/ijbs.64350 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cytotoxic Effects of a Novel tagged Apoptin on Breast Cancer Cell Lines.
Adv Biomed Res
July 2024
Molecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Article Synopsis
- Apoptin is a promising anticancer protein that selectively induces apoptosis in tumor cells, particularly in breast cancer lines, highlighting its potential for cancer therapy.
- Researchers successfully created two forms of apoptin fusion proteins (SUMO-PTD4-Apoptin and PTD4-Apoptin) and tested their effects on breast cancer cells (MDA-MB-231 and MCF-7) and normal cells (MCF-10A) using various assays.
- Results showed that SUMO-PTD4-Apoptin demonstrated a lower IC50 value in cancer cells than in normal cells, indicating higher cytotoxicity, while PTD4-Apoptin had similar effects across both cancer
Ad-VT causes ovarian cancer A2780 cell death via mitochondrial apoptosis and autophagy pathways.
Transl Oncol
October 2024
Department of Gynecologic Oncology, First Hospital of Jilin University, Changchun 130021, PR China. Electronic address:
Article Synopsis
- The study investigates the mechanism of a recombinant adenovirus, Ad-VT, which has a dual action against ovarian cancer cells, specifically targeting apoptosis and autophagy.
- Using various laboratory techniques, the research demonstrates that Ad-VT significantly inhibits the growth of ovarian cancer cells while sparing normal cells, showing effective tumor suppression in an animal model.
- The results indicate that Ad-VT primarily induces apoptosis through the endogenous pathway and enhances autophagy in cancer cells, which serves as a protective mechanism against cell death.
A novel recombinant adenovirus expressing apoptin and melittin genes kills hepatocellular carcinoma cells and inhibits the growth of ectopic tumor.
Invest New Drugs
August 2024
Key Laboratory of Smart Breeding (Co-construction by Ministry and Province), Ministry of Agriculture and Rural Affairs, Tianjin Agricultural University, Tianjin, 300392, China.
HCC is the most common fatal malignancy. Although surgical resection is the primary treatment strategy, most patients are not eligible for resection due to tumor heterogeneity, underlying liver disease, or comorbidities. Therefore, this study explores the possibility of multi-molecular targeted drug delivery in treating HCC.
View Article and Find Full Text PDFCocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically.
J Pharm Anal
June 2023
Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Intensive cancer treatment with drug combination is widely exploited in the clinic but suffers from inconsistent pharmacokinetics among different therapeutic agents. To overcome it, the emerging nanomedicine offers an unparalleled opportunity for encapsulating multiple drugs in a nano-carrier. Herein, a two-step super-assembled strategy was performed to unify the pharmacokinetics of a peptide and a small molecular compound.
View Article and Find Full Text PDFSemisynthesis reveals apoptin as a tumour-selective protein prodrug that causes cytoskeletal collapse.
Chem Sci
April 2023
Department of Chemistry, King's College London Britannia House, 7 Trinity Street London SE1 1DB UK
Apoptin is a small viral protein capable of inducing cell death selectively in cancer cells. Despite its potential as an anticancer agent, relatively little is known about its mechanism of toxicity and cancer-selectivity. Previous experiments suggest that cancer-selective phosphorylation modulates apoptin toxicity, although a lack of chemical tools has hampered the dissection of underlying mechanisms.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!